<- Go Home
Euroapi S.A.
Euroapi S.A. develops, manufactures, markets, and distributes active pharmaceutical ingredients and intermediates used in the formulation of medicines for human and veterinary use in France, Europe, Rest of Europe, North America, the Asia Pacific, and internationally. The company offers contract development manufacturing organization for different classes of tides that uses solid phase chemistry; particle engineering; microbial fermentation; small molecules synthesis; prostaglandins; steroids and hormones; and opiates and controlled substances. It provides their products to pharmaceutical, generic drug manufacturers, animal health product manufacturers, consumer health, nutrition and cosmetic product companies, biotech companies, and distribution companies, as well as contract development and manufacturing organization. Euroapi S.A. was incorporated in 2020 and is based in Paris, France.
Market Cap
EUR 306.8M
Volume
329.9K
Cash and Equivalents
EUR 73.0M
EBITDA
EUR 48.3M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
EUR 142.4M
Profit Margin
15.49%
52 Week High
EUR 4.54
52 Week Low
EUR 2.26
Dividend
N/A
Price / Book Value
0.31
Price / Earnings
-2.33
Price / Tangible Book Value
0.32
Enterprise Value
EUR 302.9M
Enterprise Value / EBITDA
5.51
Operating Income
-EUR 13.1M
Return on Equity
13.67%
Return on Assets
-0.53
Cash and Short Term Investments
EUR 73.0M
Debt
EUR 69.1M
Equity
EUR 983.5M
Revenue
EUR 919.2M
Unlevered FCF
EUR 132.2M
Sector
Pharmaceuticals
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium